FedRAMP Compliance in Healthcare: Electronic Signature

The convergence between US cloud regulations and European health data security standards is redefining the selection criteria for digital tools in the medical sector. For organisations operating at the intersection of US federal and European markets—hospitals, pharmaceutical laboratories, transnational health service providers—FedRAMP compliance in the healthcare sector with electronic signature has become a strategic imperative, rather than merely a checkbox.

This article decrypts the foundations of the FedRAMP programme, its articulation with the French HDS (Health Data Hosting) certification, and how secure electronic signature fits into this dual regulatory framework. It is intended for IT Directors, Data Protection Officers, Medical Affairs Directors and Compliance Officers who must make technology choices with major legal and operational consequences.

Understanding the FedRAMP Programme and its Requirements for the Healthcare Sector

What is FedRAMP?

The Federal Risk and Authorization Management Program (FedRAMP) is a US government programme created in 2011 under the authority of the Office of Management and Budget (OMB). It standardises the evaluation of security, authorisation and continuous monitoring of cloud services intended for US federal agencies. In 2023, the FedRAMP Authorization Act was signed, permanently codifying the programme in federal law (44 U.S.C. § 3607).

To obtain FedRAMP authorisation, a cloud service provider (CSP) must demonstrate compliance with the security controls defined in NIST SP 800-53. Three impact levels exist: Low, Moderate and High. In the federal health sector—which notably includes the Department of Veterans Affairs (VA), the Department of Health and Human Services (HHS), the Centers for Medicare & Medicaid Services (CMS)—the High level is frequently required, due to the sensitivity of PHI (Protected Health Information) data covered by HIPAA.

HIPAA, FedRAMP and the Documentary Compliance Chain

The articulation between HIPAA (Health Insurance Portability and Accountability Act of 1996) and FedRAMP creates a dual constraint for SaaS electronic signature solutions deployed in a federal healthcare context. HIPAA imposes strict rules on the confidentiality (Privacy Rule) and security (Security Rule) of PHI, whilst FedRAMP certifies that the cloud infrastructure on which the solution is based complies with auditable and continuous security standards.

Concretely, a provider offering electronic signature solutions in healthcare to US federal entities must:

• Obtain or rely on a FedRAMP ATO (Authority to Operate) issued by a sponsoring agency or via the Joint Authorization Board (JAB);
• Sign a Business Associate Agreement (BAA) HIPAA with client institutions;
• Ensure audit logging of each signature act, in accordance with document integrity requirements;
• Guarantee data residency in approved geographic regions.

FedRAMP Levels and Their Impact on Electronic Signature

The choice of FedRAMP level directly conditions the technical architecture of the signature solution. At the High level, requirements notably include:

• AES-256 encryption for data at rest and TLS 1.2+ for data in transit;
• Multi-factor authentication (MFA) mandatory for all administrative access;
• Immutable audit logs and minimum retention of 3 years;
• Monthly vulnerability scans and annual penetration testing by accredited third parties (3PAO—Third-Party Assessment Organisation);
• Continuous security incident management with notification to US-CERT within 1 hour.

These technical requirements create a documentary security standard that often exceeds that required in the European framework alone, making dual FedRAMP/HDS compliance particularly demanding.

HDS and FedRAMP: Dual Compliance for Transnational Actors

The HDS Certification: The French Reference Framework

In France, health data hosting is governed by article L.1111-8 of the Health Code, supplemented by decree no. 2018-137 of 26 February 2018. Any host processing health data of a personal nature on behalf of healthcare professionals or institutions must obtain HDS certification issued by an organisation accredited by COFRAC.

HDS certification is based on six hosting activities (physical infrastructure, virtual infrastructure, hosting platform, administration and operations, backup, managed services) and relies on ISO/IEC 27001 and ISO/IEC 27701 frameworks. For a electronic signature solution compliant with European regulations, being hosted by an HDS-certified actor is not optional when signed documents contain health data.

Points of Convergence and Divergence between FedRAMP and HDS

Comparison between the two frameworks reveals substantial points of convergence but also notable divergences:

Common points:

• Requirement for documented management of security risks;
• Strict access controls and principle of least privilege;
• Business continuity plan (BCP) and disaster recovery plan (DRP) tested periodically;
• Traceability of access to sensitive data.

Major divergences:

• Data residency: HDS is geographically neutral but implicitly favours the EU; FedRAMP generally requires hosting on US soil (FedRAMP High often mandates dedicated GovCloud environments);
• Audit model: FedRAMP uses 3PAOs accredited by the programme itself; HDS relies on certification bodies accredited by COFRAC;
• Renewal cycle: FedRAMP mandates continuous monitoring (ConMon) with monthly reports; HDS requires a triennial renewal audit.

These divergences require solutions operating in both markets to maintain separate cloud architectures or to use hyperscalers with both AWS GovCloud FedRAMP High ATO and HDS-certified infrastructure in Europe.

Electronic Signature as a Compliance Tool in Healthcare Workflows

Probative Value and Document Integrity

In a regulated environment such as healthcare, the legal value of electronic signature rests on two pillars: document integrity (non-alteration after signature) and reliable identification of the signatory (authentication). These two requirements lie at the heart of both the eIDAS regulation and the NIST standards used by FedRAMP.

The eIDAS Regulation No. 910/2014 distinguishes three levels of signature: simple (SES), advanced (AdES) and qualified (QES). In the European healthcare sector, advanced electronic signature (AdES), compliant with ETSI EN 319 132 standards for XAdES, CAdES and PAdES formats, is generally recommended for sensitive medical documents (informed consent, e-prescriptions, clinical research records).

In the United States, the applicable framework is the ESIGN Act (Electronic Signatures in Global and National Commerce Act of 2000) and the UETA (Uniform Electronic Transactions Act), which recognise the legal validity of electronic signatures without imposing a specific technical format. However, in a FedRAMP context, technical security requirements (encryption, audit trail, MFA) de facto impose a level equivalent to European AdES.

Authentication of Healthcare Professionals and Digital Identity

One of the specific challenges in the healthcare sector is the strong authentication of professionals. In France, the Health Professional Card (CPS) and its digital equivalent e-CPS, managed by ANS (National Digital Health Agency), constitute the foundation of digital identity recognised for accessing healthcare systems and signing medical documents. Integrating e-CPS into an electronic signature solution makes it possible to achieve the qualified signature level (QES) for cases requiring the highest probative value.

On the US side, the PIV (Personal Identity Verification, FIPS 201) is the equivalent federal identity standard. Federal health agencies often require PIV authentication for highly sensitive transactions, which requires signature solutions to integrate connectors compatible with this infrastructure.

For organisations seeking to understand all available options, the comparison of electronic signature solutions allows evaluation of the authentication levels supported by each platform.

Management of the Healthcare Document Lifecycle

FedRAMP/HDS compliance does not end with the signing act. It covers the entire documentary lifecycle:

• Creation and templating: models of informed consent, admission forms or research protocols must be versioned and auditable;
• Signature and timestamping: each signature must be accompanied by qualified timestamping (RFC 3161) guaranteeing the certain date of the act;
• Evidentiary archiving: the preservation of signature proofs (audit report, certificates, document hash) must comply with legal retention periods—minimum 10 years for medical records in France (article R.1112-7 Health Code), 6 years for HIPAA records;
• Revocation and invalidation: mechanisms OCSP (Online Certificate Status Protocol) or CRL (Certificate Revocation List) must allow verification of certificate validity at the time of signature.

This approach to the complete lifecycle is part of a broader effort in electronic signature for enterprises seeking to industrialise their documentary processes in a compliant manner.

Evaluating and Choosing a Signature Solution Compatible with FedRAMP and HDS

Technical Selection Criteria

Faced with the complexity of the dual FedRAMP/HDS framework, the selection criteria for an electronic signature solution in the healthcare sector must cover several dimensions:

Infrastructure and hosting:

• Active HDS certification, verifiable on the ANS PSCE registry;
• Documented FedRAMP ATO, verifiable on the official marketplace.fedramp.gov;
• Segregation of EU/US environments with data transfer policies compliant with the Data Privacy Framework (DPF);
• SLA availability ≥ 99.9% with RTO commitment < 4h and RPO < 1h.

Compliance features:

• Native support for AdES levels (XAdES, PAdES, CAdES) with RFC 3161 timestamping;
• e-CPS and PIV connectors for professional authentication;
• Documented REST API for integration into healthcare IT systems (EHR, HIS, PACS);
• Compliance dashboard with audit report export in standard format.

Contractual capabilities:

• HIPAA BAA available as standard;
• GDPR DPA (Data Processing Agreement) compliant with article 28;
• Audit clause allowing independent verification.

Integration into Healthcare Information Systems

Integration of a signature solution into a complex healthcare IT system is often the limiting factor in adoption. HL7 FHIR (Fast Healthcare Interoperability Resources) interfaces, now standard in the United States under the impetus of the 21st Century Cures Act, and DMP/Mon Espace Santé integrations in France, impose interoperability constraints that the signature solution must honour.

Organisations already equipped with existing solutions (DocuSign, Adobe Sign) can benefit from migration to a solution better suited to HDS requirements, allowing preservation of documentary archives whilst gaining regulatory compliance.

The ROI calculator available on Certyneo allows precise evaluation of the return on investment of such a migration, integrating compliance costs, productivity gains and reduction of legal risks.

Legal Framework Applicable to Electronic Signature in Healthcare: FedRAMP, HDS and eIDAS

Fundamental European Texts

In French and European law, the legal value of electronic signature rests on article 1366 of the Civil Code, which provides that "electronic writing has the same probative force as writing on paper, provided that the person from whom it emanates can be duly identified and that it is established and preserved in conditions that guarantee its integrity". Article 1367 of the Civil Code clarifies that the electronic signature "consists in the use of a reliable identification process guaranteeing its link with the act to which it is attached".

At the European level, Regulation (EU) No. 910/2014 eIDAS (Electronic Identification, Authentication and Trust Services) constitutes the foundation for mutual recognition of electronic signatures between Member States. It defines three signature levels (SES, AdES, QES) and establishes the principle that a qualified electronic signature "has a legal effect equivalent to that of a handwritten signature" (art. 25, §2). The eIDAS 2.0 Regulation (Regulation (EU) 2024/1183), which came into force in May 2024, extends this framework with the introduction of the European Digital Identity Wallet (EUDI Wallet), directly applicable to the healthcare sector for identification of patients and professionals.

The reference technical standards are published by ETSI: ETSI EN 319 101 (general policy), ETSI EN 319 132 (XAdES), ETSI EN 319 122 (CAdES) and ETSI EN 319 142 (PAdES). These standards define long-term archive (LTA) signature formats, essential to guarantee verifiability of signatures over conservation periods of 10 to 30 years.

Protection of Health Data: GDPR and Sectoral Law

Regulation (EU) 2016/679 (GDPR) classifies health data as "personal data concerning health" falling under special categories (art. 9), whose processing is in principle prohibited except for explicit exceptions (consent, necessity for care, public interest in public health). Any signature solution processing health data must comply with the principles of minimisation, limitation of purpose and security (art. 5 and 32 GDPR), and designate a data processor via a DPA compliant with article 28.

In French law, article L.1111-8 of the Health Code requires the use of an HDS-certified host for any storage of personal health data. Violation of this obligation is subject to criminal penalties (article L.1115-1 Health Code).

US Framework: HIPAA, FedRAMP and ESIGN Act

In the United States, the HIPAA Security Rule (45 CFR Part 164) imposes administrative, physical and technical safeguards for the protection of ePHI (electronic Protected Health Information). Cloud solution providers must sign a mandatory Business Associate Agreement (BAA).

The FedRAMP Authorization Act (codified in 2022, 44 U.S.C. § 3607) makes FedRAMP compliance mandatory for any cloud service used by a federal agency. Compliance violations can result in revocation of the ATO and exclusion from the federal market. The ESIGN Act (15 U.S.C. § 7001 et seq.) guarantees the legal validity of electronic signatures in commercial and federal transactions, without imposing a technical format but subject to compliance with authentication requirements.

Finally, the NIS2 Directive (Directive (EU) 2022/2555), transposed into French law by law no. 2023-703 of 1 August 2023, strengthens cybersecurity obligations for essential entities, a category in which most significant-sized healthcare institutions fall. It imposes incident notification to competent authorities (ANSSI in France) within 24 hours and engages the responsibility of managers in case of breach.

Use Cases: FedRAMP, HDS and Electronic Signature in Healthcare

Scenario 1: A University Hospital Group Managing Transatlantic Clinical Research Protocols

A hospital group of approximately 1,200 beds, partner of a US federal medical research agency (NIH-affiliated institution type), conducts phase III clinical trials involving investigator centres in France and the United States. Each patient inclusion requires electronically signed informed consent, archived for 15 years in accordance with ICH E6(R2) Good Clinical Practice requirements.

Before implementing a FedRAMP/HDS-compliant solution, the process relied on digitised paper signatures, generating average delays of 4 to 7 working days per inclusion file and a documentary error rate of 12% (incomplete forms, missing signatures). After deploying an advanced electronic signature solution, hosted on HDS-certified infrastructure in Europe and with FedRAMP Moderate ATO for US centres:

• Reduction in inclusion delay from 4-7 days to less than 24 hours (80 to 85% gain);
• Documentary error rate reduced to less than 1% thanks to automated validation workflows;
• Audit compliance: 100% of consents archived with RFC 3161 timestamping and signature proof exportable in one click for regulatory inspections FDA/ANSM.

Scenario 2: A Medical Software Editor Certifying Its Solution with US Federal Agencies

A French SME specialising in electronic health record management software wishes to commercialise its solution to US Veterans Affairs (VA) hospitals. Access to this federal market requires a FedRAMP High ATO, given that the solution integrates an electronic signature module for prescriptions and operative reports.

The company calls on a SaaS signature editor already holding a FedRAMP High ATO as a technical subcontractor, allowing it to benefit from an inherited controls compliance programme reducing by 40% the surface of controls to be audited by its own 3PAO. The total cost of the certification process is thus reduced by 35 to 50% compared to independent certification, and the time to obtain ATO is shortened from 18 months to approximately 10 months.

Scenario 3: A Network of Medical Analysis Laboratories Dematerialising Its Biology Reports

A network of 45 private medical analysis laboratories, distributed across several French regions, must affix electronic signatures from responsible medical biologists to each results report, in accordance with article L.6211-9 of the Health Code. With approximately 8,000 reports produced per day, the chosen solution must support mass signature whilst guaranteeing individual authentication of each biologist via their e-CPS.

Integration of an e-CPS-compatible signature solution, hosted by an HDS-certified provider, enables:

• Signature of 8,000 documents/day with processing times below 3 seconds per document;
• Complete audit trail exportable for inspections by ANSM and the High Authority for Health;
• Reduction in printing and postal shipping costs of approximately €60,000 per year at the network scale, according to ranges usually observed in sector reports on hospital dematerialisation (ANAP report 2024).

Conclusion

FedRAMP compliance in the healthcare sector with electronic signature represents one of the most complex regulatory challenges for organisations operating at the transatlantic scale. It requires simultaneous mastery of American frameworks (FedRAMP, HIPAA, ESIGN Act) and European frameworks (eIDAS, HDS, GDPR, NIS2), as well as a technical architecture capable of meeting the requirements of both environments without compromise on security or the legal value of signed acts.

Organisations that anticipate this dual compliance gain agility in contracting, credibility with institutional partners and resilience in the face of regulatory audits. Electronic signature, far from being merely a dematerialisation tool, becomes a structuring lever of documentary governance in healthcare.

Certyneo supports healthcare actors in implementing HDS-compliant signature workflows, eIDAS and compatible with FedRAMP requirements. Contact our experts for an analysis of your regulatory situation and a personalised demonstration.